Skip to main content
. 2017 May 26;8(43):74129–74138. doi: 10.18632/oncotarget.18273

Table 3. Association between TSHR mRNA expression and recurrence in patients with PTC (N = 61).

TSHR mRNA expression No. of recurrences/No. of patients HR, 95% CI
Low 3/14 1.0
High 3/47 4.1(1.7–6.4)

Reference group

HR (hazard ratio): adjusted by age, sex, stage, treatment etc.